Clearmind Medicine Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by HRT FINANCIAL LP, was filed 12 Jun 2026.
Who traded when
BuySaleSince the insiders bought
- -77.6%Entry US$26.96 · Close 21 Oct 2026 US$6.03
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended October 2025 · cache
- 22,139 shares@ US$3.30616.2% of flowClass A SharesSEC:0001475597-26-000092:0
- 3,183 shares@ US$3.322.3% of flowCommon StockSEC:0001475597-26-000091:0
- 2,102 shares@ US$3.361.6% of flowCommon StockSEC:0001475597-26-000082:0
- 225,191 shares@ US$0.1236.2% of flowCommon StockSEC:0001475597-26-000080:1
- 2,159,052 shares@ US$0.15373.7% of flowCommon StockSEC:0001475597-26-000080:0Canonical exit: 8 Sept 2026 (T+90)
- 13,454 shares@ CA$8.2777.8% of flowCommon SharesTSXSEDI:4512181
- 9,461 shares@ CA$1.006.6% of flowCommon SharesTSXSEDI:4512188
- 109,167 shares@ CA$0.1511.5% of flowCommon SharesTSXSEDI:4512177
- 5,827 shares@ CA$1.004.1% of flowCommon SharesTSXSEDI:4512190
- 870,000 sharesCommon SharesTSXSEDI:4175129
- 64,444 sharesCommon SharesTSXSEDI:4146392
11 of 11 declarations
About Clearmind Medicine Inc.
One filer stands out in the record of Clearmind Medicine Inc.: HRT Financial LP, a 10% owner, signs 5 of the 11 filings in June 2026. A purchase of EUR 286,361 on June 10, 2026 is followed by 4 sales: EUR 23,928 on June 11, EUR 9,115 on June 15 and EUR 63,042 on June 16, or EUR 102,185 in total and a median of EUR 16,521. Purchases are only 20% of open-market trades.
Alan Rootenberg, director and senior officer, appears in 4 filings, with no purchase or sale. Amitay Weiss, a director, and Gadi Levin, director and senior officer, have one each. The record also holds 2 option exercises and 4 filings that are neither purchases nor sales.
Read moreShow less
Four insiders filed 11 times between June 20, 2023 and June 18, 2026: 2 in 2023, 4 in 2025 and 5 in 2026. The 5 filings of 2026 are also those of the last twelve months, with 1 purchase and 4 sales. They are published a median of 2 days after the trade. The Nasdaq-listed Health Care company has a market capitalisation of USD 3,161,127.
